Clinical Trials Logo

Primary Lymphedema clinical trials

View clinical trials related to Primary Lymphedema.

Filter by:
  • None
  • Page 1

NCT ID: NCT06327412 Not yet recruiting - Aerobic Exercise Clinical Trials

The Effects of Aerobic Exercise in Patients With Primary Lower Extremity Lymphedema

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

Our aim in this study is to evaluate the effects of lymphedema on exercise capacity, body composition, functional level and quality of life in lymphedema patients with primary lower extremity involvement.

NCT ID: NCT04919655 Recruiting - Primary Lymphedema Clinical Trials

Primary Lymphedema and Mutation CELSR1 (Cadherin EGF LAG Seven-pass G-type Receptor 1)

CELSR1
Start date: February 1, 2021
Phase:
Study type: Observational

The investigators will describe the expression of mutation CELSR1 with codon stop and amino acids substitution mechanism in primary lymphedema, in both clinical examination and imaging exploration

NCT ID: NCT02988479 Completed - Primary Lymphedema Clinical Trials

Out-of Pocket Payments in Patients With Lymphedema

Lymphorac2
Start date: July 2016
Phase:
Study type: Observational

Primary lymphedema is a chronic condition posing a high burden on patients. Clinical guidelines emphasize the role of compression therapy by prescription medical devices. Even in a mandatory publicly funded health insurance system, out-of-pocket payments (OOPP) may exist due to the price and reimbursement setting processes. OOPP may threaten the equity of care and drive patients to forgo care. The investigators aim was to analyze the distributive effects of OOPP for primary lymphedema patients in France. A prospective, multicenter study will be conducted in France in 2015 on patients with primary lymphedema. Household ability to pay will be specified by net income and OOPP will be assessed prospectively over 6 months for outpatient care (visits, drugs, medical devices, nursing care, biological tests, imaging, physiotherapy and transportations). Both mandatory and voluntary health insurance reimbursements will be considered. The investigators will combine concentration curves and concentration indices to assess the distributive effects.

NCT ID: NCT02595996 Terminated - Primary Lymphedema Clinical Trials

Propranolol Dose Escalation in Lymphedema in Patients

Start date: June 7, 2017
Phase: Phase 2
Study type: Interventional

This is a study to investigate the safety and efficacy of propranolol in the treatment of patients with primary lymphedema. The primary goal is to assess patient tolerability of increasing doses of propranolol. The secondary goal is to assess lymphedema symptoms and signs in response to propranolol treatment.

NCT ID: NCT01748604 Completed - Clinical trials for Secondary Lymphedema

Physical Therapies in the Decongestive Treatment of Lymphedema

Start date: February 2004
Phase: N/A
Study type: Interventional

The purpose of this multicenter randomised controlled study is to determine whether manual lymphatic drainage (MLD) brings any benefit when added to intermittent pneumatic compression (IPC) plus multilayer, multicomponent bandages (MB) in the decongestive lymphatic therapy (DLT) in patients with lymphedema